Clinical Trials Logo

Clinical Trial Summary

The primary objective of this study is to assess the efficacy and safety of combination therapy of a Barrier Renew Cleanser, Barrier Renew PM Moisturizer, and mineral sunscreen in the treatment of redness.


Clinical Trial Description

Enrolled subjects will undergo treatment with Barrier Renew Cleanser, Barrier Renew PM Moisturizer, and mineral sunscreen. Cleanser and Barrier Renew PM moisturizer will be used twice daily. Mineral sunscreen will be used every morning and throughout the day as indicated. Subjects satisfying all inclusion and exclusion criteria will be enrolled in this trial. Prior to receiving any study treatment, mandatory photography using the VISIA system will be done. Patients will return for follow-up assessments at week 2, 4 and 8. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05961579
Study type Interventional
Source Goldman, Butterwick, Fitzpatrick and Groff
Contact Andrea Pacheco
Phone 858-657-1004
Email apacheco@clderm.com
Status Not yet recruiting
Phase Phase 3
Start date August 11, 2023
Completion date November 30, 2023